Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
07/20/2011 | CN102125622A Detection method of traditional Chinese medicine preparation for clearing away heat and toxic material, removing food retention and regulating stomach |
07/20/2011 | CN102125614A Preparation method of traditional Chinese medicine composition for treating common cold of children |
07/20/2011 | CN102125598A Quality control method of watermelon frost |
07/20/2011 | CN102125583A Pediatric paracetamol, cow-bezoar and chlorphenamine maleate granules and quality control method thereof |
07/20/2011 | CN102125541A Compound thiamphenicol injection and preparation method thereof |
07/20/2011 | CN102125540A Pharmaceutically acceptable composition containing ambroxol in non-salt form |
07/20/2011 | CN102125249A Drying method of momordica grosvenori and momordica grosvenori obtained by using same |
07/20/2011 | CN102125248A Method for performing microwave drying on grosvener siraitia and grosvener siraitia dried by same |
07/20/2011 | CN102125136A Nose-throat-ear medicinal tea |
07/20/2011 | CN101816668B Medical application of 2-O-alpha-L-rhamnose-4,6,4'-trihydroxybenzophenone |
07/20/2011 | CN101804149B Traditional Chinese medicine for treating faucitis |
07/20/2011 | CN101797253B Bergenin and cetirizine dihydrochloride compound oral administration preparation |
07/20/2011 | CN101732406B Quality detecting method for indigowoad root heat removing pellet |
07/20/2011 | CN101721449B Method for preparing lindley eupatorium herb general flavone by using attapulgite adsorption method |
07/20/2011 | CN101664485B Traditional Chinese medicine for treating respiratory disease of livestock and preparation method thereof |
07/20/2011 | CN101653448B Veterinary compound terramycin injection and preparation method thereof |
07/20/2011 | CN101647863B Quality control method of fructus xanthil dripping pills for treating rhinitis |
07/20/2011 | CN101569684B Inhalation aerosol of plant extract for treating asthma and preparation method |
07/20/2011 | CN101288706B Xanthium sibiricum honey compound soup for treating nasal sinusitis |
07/20/2011 | CN101264081B Compound for treating pulmonary fibrosis |
07/20/2011 | CN101248077B P38 map kinase inhibitors and methods for using the same |
07/20/2011 | CN101239971B Biphenyl derivatives |
07/20/2011 | CN101239970B Biphenyl derivatives |
07/20/2011 | CN101239969B Biphenyl derivatives |
07/20/2011 | CN101239968B Biphenyl derivatives |
07/20/2011 | CN101234147B Method of preparing total flavones of tropaeolum for injections |
07/20/2011 | CN101167841B Medicine for curing venereal disease and inflammation |
07/20/2011 | CN101104037B Internal-applied traditional Chinese medicine for treating damp-heat type child asthma |
07/20/2011 | CN101073595B Glycyrrhiza total flavonoid and total saponin extract and its production |
07/20/2011 | CN101023987B Method for preparing medicine for treating allergic rhinitis |
07/19/2011 | US7982067 Phenethanolamine derivatives for treatment of respiratory diseases |
07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
07/19/2011 | US7982025 Fusion proteins of Mycobacterium tuberculosis |
07/19/2011 | US7982015 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
07/19/2011 | US7981598 Preventive/remedy for respiratory diseases |
07/19/2011 | US7981443 Administration of therapeutically effective amount of topiramate over sleep period of patient |
07/19/2011 | US7981427 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43 |
07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
07/19/2011 | CA2485677C Methods of treating allergic reactions |
07/19/2011 | CA2476186C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
07/19/2011 | CA2475818C Aryl ureas as kinase inhibitors |
07/19/2011 | CA2472713C N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
07/19/2011 | CA2459165C Dosage forms having prolonged active ingredient release |
07/19/2011 | CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands |
07/19/2011 | CA2440890C Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
07/19/2011 | CA2291740C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
07/14/2011 | WO2011085256A2 Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent |
07/14/2011 | WO2011085103A2 Plasma kallikrein binding proteins |
07/14/2011 | WO2011085033A2 Dp2 antagonist and uses thereof |
07/14/2011 | WO2011084513A2 Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers |
07/14/2011 | WO2011083718A1 Agent for promoting lung regeneration |
07/14/2011 | WO2011083387A1 Hydrochloride salt of biphenyl-2-yl-carbamic acid 1-{9-[(3-fluoro-4-hydroxy-benzoyl)-methyl-amino]-nonyl}-piperidin-4-yl ester |
07/14/2011 | WO2011082732A1 Sphingosine kinase inhibitors |
07/14/2011 | WO2008060632A3 1' - substituted ribose 5 ' - polyphosphate analogs and their use as modulators of p2y receptor activity |
07/14/2011 | US20110172310 Di-fluoro containing compounds as cysteine protease inhibitors |
07/14/2011 | US20110172292 Antidote oligomers |
07/14/2011 | US20110172266 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
07/14/2011 | US20110172263 Indole derivatives as crth2 receptor antagonists |
07/14/2011 | US20110172250 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists |
07/14/2011 | US20110172237 Quinuclidine derivatives as muscarinic m3 receptor antagonists |
07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
07/14/2011 | US20110172228 Kinase inhibitors and methods of use |
07/14/2011 | US20110172202 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
07/14/2011 | US20110172195 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
07/14/2011 | US20110172191 Thieno-pyridine derivatives as mek inhibitors |
07/14/2011 | US20110172162 Chemotherapy involving antisense oligonucleotides for preventing and/or treating pulmonary fibrosis |
07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
07/14/2011 | US20110171275 Gastroretentive drug delivery system, preparation method and use thereof |
07/14/2011 | US20110171270 Novel solid state forms of laquinimod and its sodium salt |
07/14/2011 | US20110171237 Phep, an amino acid permease of staphylococcus aureus |
07/14/2011 | US20110171212 Methods and compositions for preventing radiation-induced pneumonitis |
07/14/2011 | US20110171192 Substituted amine derivative and medicinal composition comprising same as the active ingredient |
07/14/2011 | US20110171140 Absorption of therapeutic agents across mucosal membranes or the skin |
07/14/2011 | US20110171139 Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
07/14/2011 | US20110171132 Methods, Compounds, and Compositions for Treatment and Prophylaxis in the Respiratory Tract |
07/14/2011 | US20110171130 A3 adenosine receptor antagonists and partial agonists |
07/14/2011 | CA2786026A1 Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent |
07/14/2011 | CA2786019A1 Plasma kallikrein binding proteins |
07/14/2011 | CA2784647A1 Inhibitors of sphingosine kinase |
07/14/2011 | CA2784552A1 Treatment of nasal and sinus disorders |
07/14/2011 | CA2782085A1 Dp2 antagonist and uses thereof |
07/13/2011 | EP2343081A1 Interferon analogs |
07/13/2011 | EP2343077A1 Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
07/13/2011 | EP2343074A1 Use of purine analogues for treating airway diseases |
07/13/2011 | EP2343070A1 Pirfenidone treatment for patients with atypical liver function |
07/13/2011 | EP2343063A1 Pharmaceutical preparations comprising a COS releasing compound |
07/13/2011 | EP2343062A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
07/13/2011 | EP2342203A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
07/13/2011 | EP2341938A2 Use of an ang-(1-7) receptor agonist in acute lung injury |
07/13/2011 | EP2341914A2 Modulation of toll-like receptor 3 expression by antisense oligonucleotides |
07/13/2011 | EP1984001B1 Fixed-dose association of phytate and zinc |
07/13/2011 | EP1974731B1 Morphinan derivatives for use as antitussive agents |
07/13/2011 | EP1885684B1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta-2 adrenergic receptor |
07/13/2011 | EP1509489B1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
07/13/2011 | EP1486491B1 Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
07/13/2011 | CN1960759B Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
07/13/2011 | CN1903176B Dry suspensoid of Repirinast and its prepn. method |
07/13/2011 | CN1353609B Amide substituted imidazoquinolines |
07/13/2011 | CN102124003A Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders |
07/13/2011 | CN102123735A Agent for induction/maintenance of remission |